Oncology / Iressa
Oncology Pitch/Iressa
Iressa was indicated as combination therapy in non-small lung cancer.
I also designed the logo. It communicates the the intercellular mode of action of the drug.
We did win the pitch but the never went with the logo.
Iressa is indicated for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor (EGFR).
-
Role Designed logo and ad concept for the launch of Iressa
Up Next: